10:10-11:20 ROUNDTABLE 2 – Pregnancy and parenting
Chair: Jane Apperley (London)
10:10-10:15 Introduction Jane Apperley (London)
10:15-10:30 Pregnancy and TKI Elisabetta Abruzzese (Rome)
10:30-10:45 Russian recommendations to manage pregnancy in CML Ekaterina Chelysheva (Moscow)
10:45-11:00 Interferon alpha in pregnancies of Myeloproliferative Martin Griesshammer (Minden)
Neoplasms
11:00-11:20 Discussion
11:20-12:15 DEBATE 2 – Allogeneic stem cell transplantation should be considered third line option in chronic
phase CML
Chair: Andreas Hochhaus (Jena)
11:20-11:25 Introduction Andreas Hochhaus (Jena)
Audience votes YES or NO
11:25-11:40 Yes Jane Apperley (London)
11:40-11:55 No Delphine Rea (Paris)
11:55-12:15 Discussion
Audience votes again YES or NO
12:15-13:55 Lunch
12:45-13:45 SATELLITE SYMPOSIUM
Optimizing Treatment of Classical MPNs and Exploring New Options in CML
Chair: Claire Harrison (London)
Speakers: Martin Griesshammer (Minden), Massimo Breccia (Rome)
This educational symposium is organized and funded by Novartis
SESSION IV – Evolving therapies in Myelofibrosis
Chair: Ruben Mesa (San Antonio)
13:55-14:00 Introduction Ruben Mesa (San Antonio)
14:00-14:10 Interactive case: Therapy of Myelofibrosis with Ruben Mesa (San Antonio)
approved agents
14:10-14:30 Case-based lecture: Other JAK inhibitors Adam Mead (Oxford)
(Momelotinib, Pacritinib)
14:30-14:50 Case-based lecture: JAK inhibitors in combination Srdan Verstovsek (Houston)
4